Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects

1 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftEvidence-Based Medicine
Vol/bind21
Udgave nummer6
Sider (fra-til)232
ISSN1356-5524
DOI
StatusUdgivet - 2016

Citationsformater